Extension of CMV prophylaxis possible after allogeneic stem cell transplantation

被引：0
|
作者：
Freyer, Martina
机构：
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2024年 / 47卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：162 / 162
页数：1
相关论文
共 50 条
  • [41] Letermovir prophylaxis lowers the incidence of Non-CMV infections after allogeneic hematopoietic cell transplantation
    Bashey, Saffiya Z.
    Solomon, Scott R.
    Zhang, Xu
    Morris, Lawrence E.
    Holland, H. Kent
    Bachier, Lizamarie
    Solh, Melhem M.
    BONE MARROW TRANSPLANTATION, 2024, 59 (04) : 564 - 565
  • [42] Letermovir prophylaxis lowers the incidence of Non-CMV infections after allogeneic hematopoietic cell transplantation
    Saffiya Z. Bashey
    Scott R. Solomon
    Xu Zhang
    Lawrence E. Morris
    H. Kent Holland
    Lizamarie Bachier
    Melhem M. Solh
    Bone Marrow Transplantation, 2024, 59 : 564 - 565
  • [43] Application of CMV-IVIg as prophylaxis against cytomegalovirus reactivation in allogeneic hematopoietic stem cell transplantation patients
    Cui, Jiaqi
    Zhou, Yuhang
    Zhao, Kui
    Li, Xudong
    Zhang, Hanyue
    Zhang, Xiangzhong
    Sun, Yanling
    Long, Bing
    CLINICAL TRANSPLANTATION, 2024, 38 (04)
  • [44] CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation
    Michele Malagola
    Vera Radici
    Mirko Farina
    Simone Pellizzeri
    Filippo Spoldi
    Enrico Morello
    Nicola Polverelli
    Eugenia Accorsi Buttini
    Simona Bernardi
    Federica Re
    Alessandro Leoni
    Liana Signorini
    Arnaldo Caruso
    Domenico Russo
    Bone Marrow Transplantation, 2024, 59 : 138 - 140
  • [45] Cidofovir (CDV) as prophylaxis and pre-emptive therapy of Cytomegalovirus (CMV) infection in allogeneic stem cell transplantation
    Cudillo, L
    Dentamaro, T
    Postorino, M
    Picardi, A
    Rainaldi, A
    Cupelli, L
    De Laurenzi, F
    Di Caro, A
    Amadori, S
    BONE MARROW TRANSPLANTATION, 2001, 27 : S153 - S153
  • [46] CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation
    Malagola, Michele
    Radici, Vera
    Farina, Mirko
    Pellizzeri, Simone
    Spoldi, Filippo
    Morello, Enrico
    Polverelli, Nicola
    Buttini, Eugenia Accorsi
    Bernardi, Simona
    Re, Federica
    Leoni, Alessandro
    Signorini, Liana
    Caruso, Arnaldo
    Russo, Domenico
    BONE MARROW TRANSPLANTATION, 2024, 59 (01) : 138 - 140
  • [47] Clinical and Immunological Characteristics of Patients with CMV Infection after Allogeneic Hematopoietic Stem Cell Transplantation
    Chen, Man
    Zhao, Wei
    Fu, Minjing
    Lu, Peihua
    Wang, Hui
    BLOOD, 2024, 144 : 4874 - 4874
  • [48] QuantiFERON®-CMV for immune-monitoring after allogeneic stem cell transplantation:: preliminary data
    Morello, E.
    Cavattoni, I.
    Pagani, E.
    Monsurro, V.
    Coin, S.
    Cortelazzo, S.
    Larcher, C.
    Tridente, G.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S240 - S240
  • [49] CMV infection and disease after allogeneic stem cell transplantation with reduced-intensity conditioning
    Avetisyan, G.
    Hagglund, H.
    Hassan, Z.
    LeBlanc, K.
    Mattsson, J.
    Ringden, O.
    Winiarski, J.
    Ljungman, P.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S241 - S242
  • [50] Viral load as risk factor for development of CMV disease after allogeneic stem cell transplantation
    Ljungman, P
    Jonsson, J
    Sparrelid, E
    Aschan, J
    Barkholt, L
    Larsson, K
    Lewensohn-Fuchs, I
    Winiarski, J
    Yun, Z
    Ringdén, O
    BONE MARROW TRANSPLANTATION, 2004, 33 : S24 - S24
12345